- Home
- LXU vs RAPT Comparison
LXU vs RAPT Comparison
Compare LXU & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- RAPT
- Stock Information
- Founded
- LXU 1968
- RAPT 2015
- Country
- LXU United States
- RAPT United States
- Employees
- LXU N/A
- RAPT N/A
- Industry
- LXU Major Chemicals
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- LXU Industrials
- RAPT Health Care
- Exchange
- LXU Nasdaq
- RAPT Nasdaq
- Market Cap
- LXU 612.4M
- RAPT 498.4M
- IPO Year
- LXU 1969
- RAPT 2019
- Fundamental
- Price
- LXU $8.51
- RAPT $29.83
- Analyst Decision
- LXU Buy
- RAPT Strong Buy
- Analyst Count
- LXU 3
- RAPT 9
- Target Price
- LXU $10.17
- RAPT $54.33
- AVG Volume (30 Days)
- LXU 432.6K
- RAPT 701.6K
- Earning Date
- LXU 10-29-2025
- RAPT 11-12-2025
- Dividend Yield
- LXU N/A
- RAPT N/A
- EPS Growth
- LXU N/A
- RAPT N/A
- EPS
- LXU N/A
- RAPT N/A
- Revenue
- LXU $585,065,000.00
- RAPT N/A
- Revenue This Year
- LXU $12.10
- RAPT N/A
- Revenue Next Year
- LXU N/A
- RAPT N/A
- P/E Ratio
- LXU N/A
- RAPT N/A
- Revenue Growth
- LXU 12.49
- RAPT N/A
- 52 Week Low
- LXU $4.88
- RAPT $5.67
- 52 Week High
- LXU $9.85
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- LXU 47.60
- RAPT 59.45
- Support Level
- LXU $8.21
- RAPT $29.09
- Resistance Level
- LXU $9.85
- RAPT $31.00
- Average True Range (ATR)
- LXU 0.45
- RAPT 3.12
- MACD
- LXU -0.07
- RAPT -0.49
- Stochastic Oscillator
- LXU 18.29
- RAPT 26.55
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.